Keon-Hyoung Song | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 01/11/202501/11/2025 by Book of Award

Prof. Dr. Keon-Hyoung Song | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Soonchunhyang University | South Korea

Prof. Dr. Keon-Hyoung Song is a distinguished researcher whose work bridges pharmaceutical sciences, drug delivery systems, and pharmacokinetics. With 708 citations, 27 scholarly publications, and an h-index of 13, his research has significantly advanced the understanding of membrane permeation enhancers, drug formulation, and solubilization strategies. His extensive portfolio includes high-impact studies on intestinal absorption mechanisms, cocrystal engineering, and pharmacokinetic optimization, published in reputed journals such as Pharmaceutics, European Journal of Medicinal Chemistry, and Journal of Controlled Release. Prof. Song’s innovations extend beyond academia, with over 25 international patents registered across the U.S., Europe, and Korea, focusing on permeation-enhancing peptides, liposomal carriers, and pharmaceutical formulations. His pioneering patents, including those on mucous membrane permeation peptides (EP 3875103, 2025) and sugar alcohol-based liposome compositions, underscore his role in translating laboratory discoveries into therapeutic applications. Licensed as both a Patent Attorney and a Pharmacist, he effectively integrates regulatory insight with scientific innovation. Prof. Song’s sustained contributions to quantitative drug analysis using LC-MS and formulation optimization have made him a leading figure in advancing next-generation drug delivery technologies and pharmaceutical development.

Profile : Scopus

Featured Publications

Jeong, D.-H., Kim, J.-W., & Song, K.-H. (2025). Improved intestinal permeation of cyclosporin A by FCIGRL-modified tight junction modulator in rats. Pharmaceutics, 17(11), 1395.

Park, G., Galdamez, A., Song, K.-H., Le, M., Kim, K., & Lin, J. H. (2024). Ethnic variation and structure–function analysis of tauopathy-associated PERK alleles. Israel Journal of Chemistry, 64(12).

Song, K.-H. (2024). Effect of tight junction-modulating FCIGRL-modified peptides on the intestinal absorption of doxorubicin in rats. Pharmaceutics, 16(5), 650.

Jiang, F.-L., Jeong, D.-H., Eom, S.-H., Lee, H.-M., Cha, B.-J., Park, J.-S., Kwon, R.-K., Nam, J.-Y., Yu, H.-S., Heo, S.-H., Kim, C.-H., & Song, K.-H. (2024). Effects of enteric-coated formulation of sodium bicarbonate on bicarbonate absorption and gastrointestinal discomfort. Nutrients, 16(5), 744.

Koo, N. R., Yoon, S., Song, K.-H., Baek, M. J., Jeon, S., & Im, J. (2024). Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy. European Journal of Medicinal Chemistry, 265, 116050.

Park, G., Xu, K., Chea, L., Kim, K., Safarta, L., Song, K.-H., Wu, J., Park, S., Min, H., Hiramatsu, N., Han, J., & Lin, J. H. (2023). Neurodegeneration risk factor EIF2AK3 (PERK) influences tau protein aggregation. The Journal of Biological Chemistry, 299(2), 102821.

Eom, Y. S., Jeong, D., Ryu, A.-R., Song, K.-H., Im, D. S., & Lee, M.-Y. (2022). Daphne odora exerts depigmenting effects via inhibiting CREB/MITF and activating AKT/ERK-signaling pathways. Current Issues in Molecular Biology, 44(8), 3312–3323.

Kim, H., Song, K.-H., Ambegaonkar, J. P., Chung, S., Jeon, K., Jiang, F. L., Eom, J. J., & Kim, C.-H. (2022). Two-megahertz impedance index prediction equation for appendicular lean mass in Korean older people. BMC Geriatrics, 22(1), 385.

Jiang, F., Tang, S., Eom, J.-J., Song, K.-H., Kim, H., Chung, S., & Kim, C.-H. (2022). Accuracy of estimated bioimpedance parameters with octapolar segmental bioimpedance analysis. Sensors, 22(7), 2681.

Yoon, Y. M., Lee, J. H., Song, K.-H., Noh, H., & Lee, S. H. (2020). Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins. Journal of Pineal Research, 68(3), e12632.

Lee, J. H., Yoon, Y. M., Song, K.-H., Noh, H., & Lee, S. H. (2020). Melatonin suppresses senescence-derived mitochondrial dysfunction in mesenchymal stem cells via the HSPA1L-mitophagy pathway. Aging Cell, 19(3), e13111.

Cha, S. J., Choi, H.-J., Kim, H.-J., Choi, E. J., Song, K.-H., Im, D. S., & Kim, K. (2020). Parkin expression reverses mitochondrial dysfunction in fused in sarcoma-induced amyotrophic lateral sclerosis. Insect Molecular Biology, 29(1), 56–65.*

Shahbaz Khan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 13/08/202513/08/2025 by Book of Award

Dr. Shahbaz Khan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Pharmacy Academy, Institute of Foreign Trade and Management University | India

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Shahbaz Khan’s academic journey reflects a strong commitment to pharmaceutical sciences, beginning with foundational studies in pharmacy and advancing through specialized postgraduate training in pharmacology. His scholarly dedication culminated in a doctoral degree in pharmaceutical sciences, where his research explored the phytochemical and pharmacological activities of Betula alnoides bark extracts. These early academic achievements not only provided him with a robust understanding of pharmacological principles but also shaped his future research interests in neuropharmacology, neuroscience, and inflammation studies.

Professional Endeavors

Dr. Khan’s professional career spans diverse academic and administrative roles in reputed institutions. He has served as a faculty member in both assistant and associate professor capacities, mentoring students at undergraduate, postgraduate, and doctoral levels. Alongside his teaching and research responsibilities, he has contributed significantly to institutional development through administrative positions such as hostel warden. His teaching philosophy combines rigorous academic training with practical exposure, ensuring that his students are well-prepared for the pharmaceutical and healthcare industries.

Contributions and Research Focus

Dr. Khan’s research portfolio is extensive and multidisciplinary, with particular emphasis on neuropharmacology, phytochemistry, and inflammation-related pathologies. His studies delve into the therapeutic potential of medicinal plants, the development of advanced drug delivery systems, and the role of nutraceuticals in managing neurodegenerative and chronic diseases. His work also encompasses nanomedicine, regenerative medicine, and targeted therapies, leading to innovations in formulations and biomedical applications. By integrating modern pharmacological techniques with traditional medicinal knowledge, he has made meaningful contributions to both preclinical research and applied therapeutic strategies.

Accolades and Recognition

Dr. Khan has earned multiple national and international honors that recognize his academic excellence and research contributions. His achievements include prestigious travel grants for participating in global scientific programs organized by international brain research organizations, as well as awards for specialized training in molecular neuropharmacology. These recognitions underscore his role as a scholar of global repute and his ability to represent Indian pharmaceutical research on international platforms.

Impact and Influence

The impact of Dr. Khan’s work extends beyond his own research, influencing students, collaborators, and the broader scientific community. His publications in high-impact journals have contributed to advancing knowledge in pharmacology, medicinal chemistry, and biomedical sciences. His patents and innovations in pharmaceutical formulations highlight his ability to bridge the gap between laboratory research and practical healthcare solutions. Through book authorship and editorial contributions, he has also enriched the academic resources available to scholars worldwide.

Legacy and Future Contributions

Dr. Khan’s legacy lies in his ability to combine teaching, research, and innovation into a cohesive professional identity. His mentorship has guided many students toward successful careers in pharmacy and research. Looking ahead, he aims to expand his research in neurotherapeutics, nanomedicine, and herbal pharmacology, with a focus on developing novel, safe, and effective treatments for neurological and inflammatory disorders. His future contributions are expected to further strengthen the role of pharmaceutical sciences in addressing global health challenges.

Publications

Exploring Betula alnoides Bark: Insilico and Preclinical Insights into its Antioxidant and Lipid-Lowering Effects in Hypercholesterolemia
Authors: Shahbaz Khan, Alka Lohani, Prashant Tiwari, Sunil Kumar Kadiri
Journal: Obesity Medicine
Year: 2025

Innovative nanomedicine for fungal infections: Advancing treatments through nanotechnology and mycological approaches
Authors: Alka Lohani, Ritika Saxena, Shahbaz Khan, Ana Figueiras, Filipa Mascarenhas-Melo
Journal: Journal of Drug Delivery Science and Technology
Year: 2025

Tailored polymeric hydrogels for regenerative medicine and drug delivery: From material design to clinical applications
Authors: Alka Lohani, Ritika Saxena, Joana Galvão Duarte, Shahbaz Khan, Ana Figueiras, Filipa Mascarenhas-Melo
Journal: International Journal of Pharmaceutics
Year: 2025

pH-responsive IPN beads of carboxymethyl konjac glucomannan and sodium carboxymethyl cellulose as a controlled release carrier for ibuprofen
Authors: Alka Lohani, Ritika Saxena, Shahbaz Khan, Filipa Mascarenhas-Melo
Journal: International Journal of Biological Macromolecules
Year: 2024

An Insight Into Neuropathic Pain: A Systemic and Up-To-Date Review
Authors: Himanshu Sharma, Tanzeeb Rani, Shahbaz Khan
Journal: International Journal of Pharmaceutical Sciences and Research
Year: 2023

Conclusion

Through unwavering dedication to research, teaching, and innovation, Dr. Shahbaz Khan has established himself as a respected authority in pharmaceutical sciences. His contributions continue to inspire students, peers, and the scientific community at large, ensuring his place as a pivotal contributor to advancements in healthcare and pharmacology.

Jin-Lu Huang | Pharmacology, Toxicology and Pharmaceutical Science | Best Scholar Award

Published on 14/05/202515/05/2025 by Book of Award

Dr. Jin-Lu Huang | Pharmacology, Toxicology and Pharmaceutical Science | Best Scholar Award

Shanghai Sixth People's Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jin-Lu Huang’s academic journey reflects a steadfast dedication to the pharmaceutical sciences. He began his higher education at Lin Yi University, earning a Bachelor’s Degree in Life Science in 2004. He then pursued a Master’s Degree in Microbiology and Biochemical Pharmacy at the China Pharmaceutical University, graduating in 2007. Driven by a passion for research, Dr. Huang completed his PhD in Pharmacy at Shanghai Jiao Tong University in 2012, laying the foundation for a research-intensive career in pharmacology and clinical applications.

Professional Endeavors

Since July 2012, Dr. Huang has served as a Pharmacist at the Department of Pharmacy, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His clinical expertise is complemented by an earlier role (2007–2008) as a Researcher at Shanghai Hengrui Pharmaceutical Co., Ltd., where he was involved in cutting-edge drug development and R&D processes.

Contributions and Research Focus

Dr. Huang's research spans ionomic metabolism, neuropathic and bone cancer pain, drug-induced side effects, and hospital pharmaceutical practices. His work often bridges basic pharmacological science with clinical application, focusing on pain modulation, calcium signaling pathways, and drug safety evaluation. He has authored over 20 peer-reviewed articles, including high-impact studies on analgesic mechanisms, store-operated calcium entry in neuropathy, and bone cancer pain ionomics. Notably, many of his papers explore pain at a molecular level, offering insights into sphingosine-1-phosphate receptors, ionomic profiles, and nuclear receptor signaling pathways.

Accolades and Recognition

Dr. Huang is a respected member of several leading professional societies including the Chinese Pharmacological Society, the International Union of Basic and Clinical Pharmacology, and the British Pharmacological Society. His extensive publication record, both as a lead author and co-investigator, reflects international recognition and collaboration. His research has appeared in journals like FEBS Open Bio, Pain, Scientific Reports, and Pharmaceutical Biology.

Impact and Influence

Dr. Huang's work has contributed significantly to the pharmacological understanding of chronic pain, particularly in the context of bone cancer and neuropathy. His analyses using bioinformatics tools like GoPubMed and his contributions to visualizing research trends have informed policy and practice in hospital pharmacy and drug safety evaluation. His studies are frequently referenced by fellow researchers and clinicians dealing with oncology-related pain and pharmaceutical practices in hospitals.

Legacy and Future Contributions

As a bridge between clinical pharmacy and laboratory research, Dr. Jin-Lu Huang is poised to leave a lasting legacy in translational pharmacology. With ongoing investigations into neuroinflammation, analgesic mechanisms, and metabolic responses to drug therapies, he continues to shape the future of personalized and precision medicine in pain management. His commitment to advancing both theoretical insights and clinical practices ensures that his contributions will benefit patients and healthcare systems for years to come.

Publications

Involvement of ionomic metabolism of both the cerebrospinal fluid and the spinal cord in the analgesic efficacy of matrine in rats
Authors: Huang JL, Tang CY, Fu Y, Wan LL, Li J, Sun XP, Hu JL, Zhang YY, Qu LY, Fu MJ, Zhang YY, Ma L, Guo C, Chen JG
Journal: Pharmaceutical Biology
Year: 2025

Bckdk-Mediated Branch Chain Amino Acid Metabolism Reprogramming Contributes to Muscle Atrophy during Cancer Cachexia
Authors: Chen L, Zhang H, Chi M, Guo C, Yang Q
Journal: Molecular Nutrition and Food Research
Year: 2024

Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain
Authors: Wang Q, Duan D, Luo C, Yang S, Ma L
Journal: Annals of Medicine
Year: 2024

Analysis of Ionomic Profiles of Spinal Cords in a Rat Model with Bone Cancer Pain
Authors: Huang JL, Chen JG, Ma L, Zhu XY, Wan LL, Li XY, Guo C
Journal: Journal of Pain Research
Year: 2024

Store-operated calcium entry mediates hyperalgesic responses during neuropathy
Authors: Wang W, Wang Q, Huang JL, Li H, Li F, Li X, Liu R, Xu M, Chen J, Mao Y, Ma L
Journal: FEBS Open Bio
Year: 2023

Ahmet Özdemir | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 23/07/202423/07/2024 by Book of Award

Prof Dr. Ahmet Özdemir | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Anadolu University | Turkey

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Ahmet Özdemir's academic journey began at Salihli Cumhuriyet Elementary School (1978-1983), followed by Salihli 50. Yıl Secondary School (1983-1986) and Salihli High School (1986-1989). His passion for pharmacy led him to Anadolu University Faculty of Pharmacy, where he completed his undergraduate studies (1990-1994). He pursued further education at the Graduate School of Health Sciences, Department of Pharmaceutical Chemistry at Anadolu University, earning a Master's degree (1995-1996) and a Doctor's degree (1996-2004).

Professional Endeavors 💼

Prof. Dr. Özdemir's professional career commenced at Anadolu University as a Research Assistant (1997-2004). He progressed to Research Assistant Doctor (2004-2005), Lecturer (2005-2007), and Assistant Professor Doctor (2007-2010). His dedication and expertise earned him the title of Associate Professor Doctor (2010-2015), and he has been serving as a Professor Doctor since 2015.

Contributions and Research Focus 🔍

Prof. Dr. Özdemir's research is marked by significant contributions to pharmaceutical chemistry. His Master's thesis focused on "The studies on the synthesis, structure elucidations and determination of physicochemical parameters of some 2-substituted-1H-phenantro[9,10-d]imidazole compounds," under the supervision of Prof. Dr. İlhan Işıkdağ. His PhD thesis, supervised by Prof. Dr. Gülhan Turan, investigated the "Synthesis of some 1-[(N,N-disubstituted-thiocarbonylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and their antifungal, antibacterial activities."

Accolades and Recognition 🏅

Prof. Dr. Özdemir's work has been widely recognized, earning him numerous awards:

Anadolu University Article Performance Award (2014, 2016, 2017, 2018, 2020)
Anadolu University Gold Article Performance Award (2015)
Anadolu University Platinum Article Performance Award (2015)
Anadolu University Academic Success Award (2019)
ISIF'21 Silver Medal for the invention "Targeted Novel Triazolothiadiazine Derivatives for The Treatment of Lung Cancer" (2021)

Impact and Influence 🌟

Prof. Dr. Özdemir's impact extends beyond research. He has held key administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School (2011-2014) and Vice Academic Director of the Anadolu University Open Education Faculty, Department of Health Administration (2015-present). His mentorship has guided many students, as evidenced by his supervision of numerous master’s and doctoral dissertations.

Legacy and Future Contributions 🚀

Prof. Dr. Özdemir’s legacy is built on his unwavering commitment to advancing pharmaceutical chemistry. His innovative research, administrative leadership, and dedication to education have left an indelible mark on Anadolu University and the broader scientific community. As he continues his work, Prof. Dr. Özdemir is poised to make further groundbreaking contributions that will shape the future of pharmaceutical sciences.

Publications

📜Title: Design, Synthesis, and Biological Evaluation of a New Series of Imidazothiazole-Hydrazone Hybrids as Dual EGFR and Akt Inhibitors for NSCLC Therapy
Authors: Mehlika Dilek Altıntop, İpek Ertorun, Gülşen Akalın Çiftçi, Ahmet Özdemir
Journal: European Journal of Medicinal Chemistry
Year: 2024

📜Title: Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents
Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
Journal: ACS Omega
Year: 2024

📜Title: Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents
Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
Journal: ACS Omega
Year: 2023

📜Title: Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
Journal: ACS Omega
Year: 2023

📜Title: A New Series of Hydrazones as Small-Molecule Aldose Reductase Inhibitors
Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
Journal: Archiv der Pharmazie
Year: 2023

📜Title: A New Series of Thiazole-Hydrazone Hybrids for Akt-Targeted Therapy of Non-Small Cell Lung Cancer
Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
Journal: Drug Development Research
Year: 2023

Simon Bernard Iloki Assanga | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 17/02/202417/02/2024 by Book of Award

Prof Dr. Simon Bernard Iloki Assanga | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Sonora | Mexico

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Simon Bernard Iloki Assanga embarked on his academic journey by obtaining a Bachelor's degree from the Pre-University Institute February 5 in Isle of Youth, Cuba, followed by a Graduate degree in Pharmaceutical Sciences from the University of Havana, Cuba. His academic pursuits culminated with a Doctorate in Pharmaceutical Sciences with a specialty in Immunology from the same institution in 2005.

Professional Endeavors

Dr. Assanga's professional career has been marked by a diverse array of roles, spanning from teaching to research. Noteworthy positions include his tenure as a Subject Teacher at the University of Sonora in Mexico, where he contributed to the Science department's Chemical-Biological sector. Additionally, he served as an Associate Full-Time Research Professor at the Department of Research and Postgraduate Studies in Food (DIPA) at the University of Sonora.

Contributions and Research Focus

Throughout his career, Dr. Assanga has made significant contributions to the field of pharmaceutical sciences and immunology. He has led various research projects, such as investigating the therapeutic potential of natural products for age-related macular degeneration and scaling up pilot plant production for nutraceuticals. His research interests also include exploring the chemical and nutritional composition of medicinal plants and their potential applications in healthcare.

Accolades and Recognition

Dr. Assanga's dedication and contributions have been recognized through numerous awards and honors. Notably, he received recognition for Outstanding Foreign Graduate from the Pharmacy Institute and Food at the University of Havana. He is also a member of prestigious scientific societies like the Society for Redox Biology and Medicine, highlighting his standing in the academic community.

Impact and Influence

Dr. Assanga's research, teaching, and participation in academic events have had a profound impact on the field of pharmaceutical sciences and immunology. His work in elucidating the therapeutic properties of natural products and mentoring students has contributed to advancements in healthcare and inspired future generations of researchers.

Legacy and Future Contributions

As a respected academic and researcher, Dr. Assanga's legacy lies in his extensive body of work, mentorship of aspiring scientists, and active participation in scientific discourse. His commitment to advancing knowledge in pharmaceutical sciences and immunology ensures that his contributions will continue to shape the field for years to come. In the future, he aims to further explore the therapeutic potential of natural products and collaborate on interdisciplinary research projects aimed at addressing pressing healthcare challenges.

Notable Publications

Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration 2022 (10)

Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass 2022 (11)

Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity 2022 (20)

Assoc Prof Dr. Nicola Micale | Pharmacology, Toxicology and Pharmaceutical Science | Best Research Award

Published on 05/01/202405/01/2024 by Book of Award

Assoc Prof Dr. Nicola Micale | Pharmacology, Toxicology and Pharmaceutical Science | Best Research Award

University of Messina | Italy

Author Profile

Scopus

Early Academic Pursuits

Associate Professor Dr. Nicola Micale commenced his academic journey with an exceptional focus on Chemistry and Pharmaceutical Technology, culminating in an honored degree from the University of Messina. This foundation laid the groundwork for his specialization in pharmacology and pharmaceutical sciences.

Professional Endeavors

Micale's career trajectory has been marked by a series of esteemed positions, from pivotal research roles to impactful lectureships across Europe. His academic pursuits have extended globally, emphasizing collaborative research ventures and immersive academic experiences.

Contributions and Research Focus

Central to Micale's contributions is his intensive focus on neurodegenerative disorders and innovative drug design. His research spans diverse areas, ranging from peptidomimetics to targeted drug development, showcasing a commitment to combatting microbial infections and malignancies.

Accolades and Recognition

Micale's exemplary research earned him notable recognition, including the Farmindustria Award for Pharmaceutical Research and invitations to deliver lectures at prestigious international conferences. These accolades affirm his expertise and contributions to the field.

Impact and Influence

Beyond his research contributions, Micale's influence is evident through his pivotal roles on the editorial boards of multiple international scientific journals. His role as a reviewer for esteemed publications underscores his commitment to shaping scholarly dialogue and validating scientific research.

Legacy and Future Contributions

Associate Professor Dr. Nicola Micale's legacy is rooted in his multidisciplinary approach to pharmaceutical sciences and his dedication to fostering global scientific collaborations. His ongoing contributions are poised to drive advancements in pharmaceutical research, leaving a lasting imprint on the field's progression and innovation.

Notable Publications

Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 M pro 2023 (5)

Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M pro Inhibitors 2023 (3)